First Phase 3 clinical trial of a coronavirus vaccine in the United States begins (cnn.com)
Savannah, Georgia The first Phase 3 clinical trial of a coronavirus vaccine in the United States began Monday.
The investigational vaccine was developed by the biotechnology company Moderna and the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. The trial is to be conducted at nearly 100 US research sites, according to Moderna. The first patient was dosed at a site in Savannah, Georgia.
- Log in to post comments
Source